In patients with type 2 diabetes mellitus (T2DM), those receiving oral glucose-lowering medication and long-acting insulin displayed higher spine bone mineral density (BMD) and serum calcium levels compared to those receiving oral glucose-lowering medication only [6]. Here, INS is linked to type 2 diabetes mellitus.